Schedule 13G ownership disclosure

OKYO PHARMA LTD

Common · CUSIP: G6724L116

Event date: 2025-03-12

Filing-level shares
1,999,380.00
Percent of class
5.9%
  • Dauntless Investment Group, LLC

    Shares: 1,999,380.00 · Class: 5.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001137439-25-000228
Form type
SCHEDULE 13G
Filer
Dauntless Investment Group, LLC
CIK
CIK 2044285
Filed
Mar 18, 2025
Reporting period
Mar 12, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub